Shenzhen Salubris Pharmaceuticals Co., Ltd.
002294
Classifica tra le azioni
#3418
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
Prezzo delle azioni
$4.48
Capitalizzazione di mercato
$4.99B
Variazione (1 giorno)
-5.20%
Variazione (1 anno)
-41.89%
Paese
CN
Scambia Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Categoria
Healthcare
Storico dividendi per Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Shenzhen Salubris Pharmaceuticals Co., Ltd. (simbolo azionario: 002294) ha effettuato un totale di 16 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: $7.30
Rendimento da dividendo (TTM): 0.0184
La somma totale dei dividendi (rettificata per split azionari) è: $7.30
Rendimento da dividendo (TTM): 0.0184
Pagamenti dei dividendi per Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) dal 2010 al 2026
Pagamenti annuali dei dividendi
| Anno | Dividendo (rettificato per split azionari) | Cambia |
|---|---|---|
| 2026 (TTM) | $0.55 | 10.00% |
| 2025 | $0.5 | 0.00% |
| 2024 | $0.5 | 0.00% |
| 2023 | $0.5 | 25.00% |
| 2022 | $0.4 | -20.00% |
| 2020 | $0.5 | -37.50% |
| 2019 | $0.8 | 0.00% |
| 2018 | $0.8 | 14.29% |
| 2017 | $0.7 | 16.67% |
| 2016 | $0.6 | 37.14% |
| 2015 | $0.4375 | 16.67% |
| 2014 | $0.375 | 28.56% |
| 2013 | $0.2917 | 86.63% |
| 2012 | $0.1563 | 20.05% |
| 2011 | $0.1302 | 139.78% |
| 2010 | $0.0543 | 0.00% |
Elenco di tutti i pagamenti di dividendi
| Anno | Dividendo | Cambia |
|---|---|---|
| 2026 (TTM) | $0.55 | 10.00% |
| 2025 | $0.5 | 0.00% |
| 2024 | $0.5 | 0.00% |
| 2023 | $0.5 | 25.00% |
| 2022 | $0.4 | -20.00% |
| 2020 | $0.5 | -37.50% |
| 2019 | $0.8 | 0.00% |
| 2018 | $0.8 | 14.29% |
| 2017 | $0.7 | 16.67% |
| 2016 | $0.6 | -14.29% |
| 2015 | $0.7 | 16.67% |
| 2014 | $0.6 | -14.29% |
| 2013 | $0.7 | 55.56% |
| 2012 | $0.45 | -25.00% |
| 2011 | $0.6 | 20.00% |
| 2010 | $0.5 | 0.00% |
Dividendi di aziende simili o concorrenti
| Azienda | Numero di pagamenti di dividendi | Il paese |
|---|---|---|
| 0.00% |
US
|
|
| 27.00% |
FR
|
|
| 52.00% |
JP
|
|
| 175.00% |
US
|
|
| 7.00% |
CH
|
